カワチ薬品 reports lower revenue and profit for the interim period of the fiscal year ending March 2027, with operating profit down 6.2% | Market Flash | Corporate Information FISCO

カワチ薬品 released its consolidated results for the second quarter (interim period) of the fiscal year ending March 2027. Revenue was ¥144,143 million, down 0.8% year on year, while operating profit fell 6.2% to ¥3,009 million.

Full text unavailableWorking from the headline and excerpt

sources corroborateOutlets reporting the same event

companies linkedAcross 0 themes, second pass

The story

カワチ薬品 released its consolidated results for the second quarter of the fiscal year ending March 2027. Revenue for the interim period was ¥144,143 million, down 0.8% year on year.

Operating profit was ¥3,009 million, down 6.2% year on year.

At a glance

PeriodInterim period of the fiscal year ending March 2027

Sales¥144,143 million, down 0.8% year on year

ProfitOperating profit of ¥3,009 million, down 6.2% year on year

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

web.fisco.jpNews

AgreesOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.